XENSE

Meta CT, 1st In The World. <1 Degree Open CT/X-ray Imaging, Ultralow Radiation

Print
Follow Claim My Business
Security Type
CAFES
Categories
Technology, Infrastructure, Healthcare & Medical, Community & Lifestyle
Min Investment
$495
Location
IRVINE, CA
Expected Close Date
April 30, 2025
Target Raise
$15.00K-$617.99K
No. Investors
103
Security Price
$3.37
Website
xense.com
Number of Employees
11
Cash
$73,908
Revenue
$0
Short Term Debt
$920,496
Cost of Goods
$0
Long Term Debt
$2,301,157
Net Income
$-361,315

Company Description

You are Making History
1st in the World Enabling Technology to Replace the Old Technologies in a $26 Billion (2026) Market
Large Patent Portfolio, 40+: first one filed already granted by the US Patent Office
X-ray is Must-To-Have and Core Imaging Modality in Healthcare

Key Deal Facts

You are Making History
1st in the World Enabling Technology to Replace the Old Technologies in a $26 Billion (2026) Market
Large Patent Portfolio, 40+: first one filed already granted by the US Patent Office
X-ray is Must-To-Have and Core Imaging Modality in Healthcare

Management Team / Advisory Board Bios

Ying Zhao CEO and FounderVetted bioimaging visionary | 3X successful track records in trend forecast & developing high growth platform imaging systems for research, diagnostics, surgical guidance for global market leaders | 3 patents granted | MS EE, Columbia University
Amount Raised : $476,507
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments